Abstract
Current advancements and prospects for next-generation CRISPR-based fast diagnostics at the point of care
Author(s): Haimedah Edde DThe advent of CRISPR technology has revolutionized molecular diagnostics, paving the way for rapid, accurate, and affordable point-of-care (POC) testing. Leveraging the precision of CRISPR-associated proteins, these diagnostics promise to address limitations in traditional methods, such as prolonged turnaround times and laboratory dependency. This article explores recent advancements in CRISPR-based POC diagnostics, highlighting their potential for detecting infectious diseases, genetic disorders, and cancer biomarkers. Additionally, we discuss challenges such as scalability, affordability, and regulatory hurdles while envisioning the future of CRISPR diagnostics in improving global healthcare outcomes.